View Full Paper

Owner Consent Verified
Case Study 4.4

Privacy And Security in Impact Investing for Pharmaceutical Firms: A Comparative Perspective

34
Pages
Chicago
Style
~ 36–49 mins
Reading Time
Cold Chain CV Governance
Abstract

This case study investigates “Privacy And Security in Impact Investing for Pharmaceutical Firms: A Comparative Perspective” using a Delphi study. Through a human-centered lens, the analysis integrates multi-source data to derive a validated measurement model for researchers and practitioners.

Download PDF Order Similar Paper Save

Privacy And Security in Impact Investing for Pharmaceutical Firms: A Comparative Perspective

ABSTRACT
Privacy And Security in Impact Investing for Pharmaceutical Firms: A Comparative Perspective is unpacked across themes: change enablement, interoperability, security, and KPIs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
26 Pages 4.4
Adoption Barriers in Carbon Markets for University Students: Evidence from Latin America
DevSecOps Risk BioMed
View Paper
19 Pages 4.7
Ethical AI and Ethical Considerations among Regulated Utilities — Evidence from DACH Region
Blockchain Psychology BioMed
View Paper
14 Pages 4.8
Microfinance and Change Management among Regulated Utilities — A systematic literature review
DevSecOps BioMed Metaverse
View Paper